PeptideDB

GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat)

CAS No.: 107444-51-9

GLP-1 (7-36) amide also called Glucagon-Like Peptide 1 (7-36) amide, Preproglucagon (98-127) amide, is secreted from the
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

CAS 107444-51-9
Sequence H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2
Sequence Single HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2
Molecular Formula C149H226N40O45
Molecular Weight 3297.68
Synonyms Glucagon-Like Peptide 1 (7-36) amide (human, bovine, guinea pig, mouse, rat), Preproglucagon (98-127) amide (human, bovine, guinea pig, mouse, rat), Proglucagon (78-107) amide (human, bovine, guinea pig, mouse, rat), Glucagon-Like Peptide I (7-36), amide,
Technology Synthetic
Storage -20°C, avoid light, cool and dry place
Application Diabetes
Description GLP-1 (7-36) amide also called Glucagon-Like Peptide 1 (7-36) amide, Preproglucagon (98-127) amide, is secreted from the lower small intestine and shows a strong insulinotropic effect. GLP-1 (7-36) amide is considered as the most important incretin hormone. Its action is mediated by receptors expressed by the endocrine pancreatic B-cells. Considerable interest has focused on the development of this peptide as a therapeutic strategy for non-insulin-dependent (type 2 ) diabetes mellitus and associated neuropathy.
References 1.  Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. C.-H.Chang et al., Molecules, 19, 19066 (2014) 2.  Glucagon-like peptide 1 (7-36) amide (GLP-1) and exendin-4 stimulate serotonin release in rat hypothalamus. L.Brunetti et al., Peptides, 29, 1377 (2008) 3.  Truncated glucagon-like peptide-1 (proglucagon 78-107 amide), an intestinal insulin-releasing peptide, has specific receptors on rat insulinoma cells (RIN 5AH). C.Orskov and J.H.Nielsen, FEBS Lett., 229, 175 (1988) 4.  Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes. M.A.Nauck et al., Exp. Clin. Endocrinol. Diabetes, 105, 187 (1997) 5.  Effects of glucagon-like peptide-1(7-36)amide on the concentrations of insulin and glucose in sheep. P.A.Martin and A.Faulkner, Comp. Biochem. Physiol. Comp. Physiol., 105, 705 (1993) 6.  Exon duplication and divergence in the human preproglucagon gene. G.I.Bell et al., Nature, 304, 368 (1983) 7.  Glucagon-like peptide-1 7-36: a physiological incretin in man. B.Kreymann et al., Lancet, 2, 1300 (1987) 8.  Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4. J.-P.Raufman et al., J. Biol. Chem., 267, 21432 (1992) 9.  The glucagon-like peptides: a double-edged therapeutic sword? T.Perry and N.H.Greig, Trends Pharmacol. Sci., 24, 377 (2003) 10.  Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus. J.J.Meier et al., Biodrugs, 17, 93 (2003)